Esperion Therapeutics Inc (ESPR)

SBC to Revenue

3.12%

Quarterly · Period ending:

ESPR logo

ESPR SBC to Revenue

Latest reported3.12%
ESPR Quarterly SBC/Revenue (0.00% → 3.12%)
High-resolution chart · PNG

ESPR sbc to revenue history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Esperion Therapeutics Inc SBC to Revenue — Quarterly
Period endingSBC to Revenue
3.1234%
1.4171%
2.6904%
3.2397%
3.7926%
4.0586%
5.853%
3.9697%
2.3487%
9.0543%
8.758%
12.2547%
11.9323%
19.7417%
18.6354%
18.7198%
23.5506%
29.0501%
38.1498%
21.1122%
72.0857%
69.2364%
189.5121%
3.4843%
383.3152%
647.4542%
644.9541%
668.3299%
4.5634%
3.7019%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.